Being HIV-1-PR an essential enzyme in the viral life cycle, its inhibition can control AIDS.
I. INTRODUCTION
HIV-1-PR is a homodimer, that is a protein whose native conformation is built of two (identical) disjoint chains each of them made of 99 amino acids. Sedimentation equilibrium experiments have shown that at neutral pH the protease folds according to a three-state mechanism (2U → 2N → N 2 ), populating consistently the monomeric native conformation N [1] . The dimer dissociation constant (2N → N 2 ) is k D = 5.8 µM at room temperature, while the folding temperature of the monomer, i.e. the temperature at which the free energy of the native monomeric state N is equal to that of the unfolded state U is T f = 52.5C [2] .
Monte Carlo simulations of the folding of three-state homodimers [3] indicate that after the monomers have reached the native state N, they diffuse to find another folded monomer to associate with. The same study also shows that in the stage U → N, each monomer folds according to the same mechanism controlling the folding of single domain proteins.
This mechanism is reasonably well understood as a result, among other things, of extensive lattice model studies as well as of all-atom off-latice Gō-model simulations (cf. ref. [4] and refs. therein). These studies revealed the central role played by few, strongly interacting highly conserved, as a rule hydrophobic, amino acids. Mutations of these "hot" amino acids lead, in general, to denaturation [5] . It has been shown [6, 7] that, starting from an unfolded conformation, folding proceeds following a hierarchical succession of events: 1) formation of LES stabilized by the interaction among "hot" amino acids lying close along the polypeptide chain, 2) docking of the LES into the (post critical) folding nucleus, that is formation of the minimum set of local contacts which brings the system over the major free energy barrier of the whole folding process, 3) relaxation of the remaining amino acids on the native structure shortly after the formation of the folding nucleus. Strong support for pared to conventional (active site centerd-) inhibitors: I) their molecular structure is direclty fixed by that of the target protein. One has thus not to design a molecule so as to optimize its interaction with a given site of the enzyme, but just find which are the LES of the protein to be inhibited. The design of the p-LES having been performed by evolution. In fact, like the pair enzyme/substrate, pairs of complementary LES have evolved through millions of years in order to learn how to recognize its partners as well as to avoid aggregation, II) it is unlikely that the protein can develop drug-resistance through mutations as LES are stabilized by hot amino acids.
The present paper is divided in two main parts. A theoretical one (Sections 2 and 3)
where the prediction of the model are presented, and an experimental one (Sect. 4), where the properties of the designed inhibitor are tested.
II. FOLDING UNITS OF HIV-1-PR: LOCAL ELEMENTARY STRUCTURES
The first step to be taken in the design of an inhibitor of the HIV-1-PR following the strategy discussed in the previous Section is to determine the LES of the target protein. In other words, segments of the protein containing highly conserved residues. To this scope use is made of evolution data input as well as model simulations.
A. Evolution
A measure of the degree of conservation of residues in a family of proteins is the entropy per site S(i) = − σ p i (σ) ln p i (σ), where p i (σ) is the frequency of appearence of residue of type σ at site i. Making use of a family of 28 uncorrelated proteins (i.e., displaying sequence similarity lower than 25%) structurally similar to HIV-1-PR [17] , the entropy S(i) was calculated for all 99 sites of the monomers. From the result shown in Fig. 1(a) (continous curve) it is observed that the most conserved regions of the proteins involve residues 24-33, 56-61 and 81-87. Note that the conservation of residues 25-27 is not unexpected in that they build the active site of the protease.
Another important source of information concerning protected sites of the HIV-1-PR stems from drug-induced mutations observed in vivo. The large production of virion in the cell, coupled with the error prone reverse transcriptase enzyme, eventually leads to escape mutants. Mutations observed in the stretches of the HIV-1-PR mentioned above are, as a rule, conservative mutations (e.g. L24I) [10, 18] . Less conservative mutations, e.g. hydrophobic to hydrophilic, are absent from these structurally protected regions.
B. Model calculations: energetics
In order to become stable at an early stage of the folding process, LES must carry a significant fraction of the total energy of the protein. We have calculated this quantity making use of short all-atom molecular dynamics simulations in explicit water using GRO-MACS software [19] . The calculation was performed at 295 K for 1 ns, during which the protein fluctuates around its native conformation (the maximum RMSD being 11Å). We have followed the scheme described in ref. [20] , calculating the average interaction energy B ij between any pair of amino acids during the 1ns dynamics and extracting the eigenvalues λ n of the resulting matrix B ij . The lowest energy state (λ 1 =-121.2 kJ/mol) displays a large energy gap (i.e. -12.9 kJ/mol≈ 5kT ) with respect to the next eigenvalue, indicating a core of strongly interacting amino acids [20] . We display in Fig. 1 Table I , the corresponding 8 × 8 energy map is essentially codiagonal, the associated energy of the interacting chain segment being −1751 kJ/mol as compared to the MD simulation native energy −2533 kJ/mol. In other words, the S 1 − S 8 representation of the folded monomer accounts for ≈ 70% of the calculated native conformation energy. In particular, the interaction between fragments S 2 , S 5 , S 7 and S 8 is stabilized by −796 kJ/mol equal to 32% of the native conformation energy. Of this energy 20% (= −503 kJ/mol) corresponds to the internal energy of the four fragments, while 12% (= −293 kJ/mol) corresponds to the summed interaction energy between fragments.
In keeping with the above results the S 2 , S 5 , S 7 and S 8 segments qualify as LES (folding units) of each of the two monomers of the HIV-1-PR dimer, LES which form in their native conformation the (post critical) folding nucleus (FN). It is interesting to note that drug induced mutations in the amino acids belonging to these LES (L24I, D30N, L33F, L63V, I64V, V77I, V82A, I84D, N88D and L90M [18, 21] ), lead to a folding nucleus energy equal to -1500 kJ/mol, as compared to -796 kJ/mol for the wild type sequence FN, that is to increase of almost a factor of 2 in the stability of the system. Cecconi and coworkers [24] have calculated the stability temperatures associated with each contact of the protease, again making use of a Gō-model. They find that key sites to the stability of partially folded states, that is those displaying the lowest stability temperatures, are 22, 29, 32, 76, 84 and 86.
D. Dynamics of contact formation
To directly investigate the folding mechanism of the HIV-1-PR monomer, use is made of a simplified model which has proven useful to account for the folding properties of a number of small, single-domain proteins [25] . The model pictures each amino acid as a spherical bead, making inextensible links with the rest of the chain. Each pair of amino acid interacts through a modified Gō-contact potential [26] 
where r i is the coordinate of the ith amino acid, ∆(|r i − r j |) is a contact function which assumes the value 1 if the ith and jth residues are closer than 6.3Å and zero otherwise, B ij being the energy matrix elements defined in Sect. 2b. Moreover, each amino acid displays a hard core of 3.8Å.
Equilibrium following an exponential dynamics. This is the case for contacts belonging to S 2 (25) (26) (27) (28) and in particular to S 8 (e.g. contacts 86-89, 87-90, 89-92, 90-93). Contacts between residues which are far along the chain are formed later, following a non-exponential dynamics, which indicate that their formation is dependent on some other event. The earliest involve the interaction between fragments S 5 − S 7 and S 2 − S 8 which take place after an average time of few and of tens of ns, respectively. As an example we display in Fig. 2 (b) the formation probability of the contact 31-89 as a function of time.
In Fig. 2(c) is summarized the hierarchy of formation of native contacts of HIV-1-PR, the different gray levels corresponding to different time scales, while in Table II From the above discussion one can conclude that peptides p-S 2 and p-S 8 are the most likely candidates as folding inhibitors of the HIV-1-PR monomer. Because S 8 is well structured (it builds 10 internal contacts and an α-helix turn), while S 2 has little internal structure, we shall select p-S 8 as the best candidate for a non-conventional inhibitor. It is expected that peptides p-S 8 will efficiently attach to the S 2 -LES, thus blocking the formation of the folding nucleus or, in the case the protein is already folded, by profiting favourable fluctuations around the native conformation, to come into contact with the S 2 -LES thus blocking the return of the monomer to the original native conformation.
III. INHIBITION OF THE FOLDING OF THE HIV-1-PR
Within the framework of the Gō model discussed above, Monte Carlo simulations were carried out for a system composed of a single 99mer and a number (from 1 to 5) of p-S 8
peptides, placed inside a box of side of 100Å with periodic boundary conditions.
In Fig. 3(a) obtained from calculations which describe the system at equilibrium they apply equally well to situations in which one starts with the monomer in the state N or in state U.
To test the validity of these results, we have repeated the simulations using peptides corresponding to fragments of the protease monomers different from the LES, but having a similar number of amino acids. It is found that e.g., fragments 9-19 and 61-70 do not have any significant effect on the free energy of the native state (cf. Fig. 3(b) ). This result testifies to the fact that the denaturing effect observed in the results shown in Fig 3(a) is due not to some unspecific interaction between the peptides and the protein, but to the very choice of LES-mimicking peptides.
To further clarify the mechanism which is at the basis of the results shown in Fig. 3(a) , we display in Fig. 4(b) a snapshot of the simulation carried out with 3 peptides. It is seen that one of the p-S 8 peptides has built (strong) contacts stabilizing the folding nucleus of the protein. Consequently, the state corresponding to the correctly folded monomer (Fig. 4(a) ) and to the state in which the peptide binds to the partially folded protein have similar energies but very different free energies. In fact, the main difference between the two conformations displayed in Fig. 4 (a) and 4(b) is entropic: while the partially folded protein has a much larger entropy as compared to the folded protein (which essentially is in a single conformation), the complexed state is penalized by the entropy decrease associated with the binding of a single peptide, decrease which can be reduced at will by increasing the number of peptides.
Consequently, whatever the folding entropy cost of binding a p-S 8 is, there exists a concentration of peptides which makes the complexed, partially-unfolded state favourable.
In the case of the present simulations, a concentration of peptides equal to few times that of the protein seems to be adequate to consistently destabilize the protease.
We have also analyzed the effect pointlike mutations [35] on the HIV-1-PR have on the inhibitng ability of p-S 8 peptides. Mutations on sites not belonging to LES have little or no effect on the stability of the protease, but at the same time do not affect the inhibitory action of p-S 8 . For example, mutations on site 73 cause the protease to decrease its stability at 300 K from 98% (observed for the "wild-type" sequence) to 97%, the effect of 3 p-S 8 peptides leading to a decrease of this stability from 97% to 32% (to be compared with the 98% to 52% decrease observed in the case of the "wild-type" sequence). Mutations in sites belonging to the LES of the HIV-1-PR, on the other hand, cause destabilization of the native state of the protease, shifting the equilibrium distribution of the order parameter q E towards lower values. For example, mutation in site 34 causes the stability of the protease to diminish to 64% (from the value of 98%).
IV. SPECTROPHOTOMETRIC MEASUREMENTS
Following the theoretical predictions discussed above, we have investigated the inhibitory properties of the peptide of sequence NIIGRNLLTQI (p-S 8 ≡ 83-93) by means of a spectrophotometric assay as described in ref. [28] and making use of ultraviolet circular dichroism [29] .
A. Materials and methods
Recombinant HIV-1-Protease, expressed in E. Coli (Sigma Cat. no. P7338) [30, 31] contained five mutations to restrict autoproteolysis (Q7K, L33I, L36I) and to restrict cysteine thiol oxidation (C67A and C95A). The enzyme was stored at (-70C as solution with concentration 25µg/63µL in dilute HCl, (pH=1.6) ). A chromogenic substrate for HIV-1-PR (Sigma Cat. no. H5535) (with sequence Arg-Val-Nle-Phe(NO 2 )-Glu-Ala-Nle-NH 2 ) was obtained as a 1 mg desiccate, diluted with 0.1 ml of DMSO, and stored at -20C. Protease assisted cleavage between the Nle and the Phe(NO 2 ) residues of substrate entails a blue-shift of the absorption maximum (277 nm to 272 nm). It can be adequately monitored observing the continuous decrease of absorbance at 310 nm [28] . A regression of the absorbance at 300 nm against substrate concentration allows to estimate the extinction coefficient of the whole substrate (S = 6300 ± 1600 (mol cm) −1 ). Moreover, the absorbance at 300 nm after complete peptidolysis allows to determine a differential extinction coefficent (= 1500 ± 250 (mol cm) −1 ) between the whole substrate and the cleaved products. This compares well with a difference of extinction coefficient at 310 nm between the cleaved and the complete substrate of 1200 ± 100 (mol cm) −1 , reported in ref. [28] . The buffer was prepared by adding 0.8 mM NaCl, 1 mM EDTA and 1 mM dithiothreitol to a 20 mM phosphate buffer (pH 6). Other peptides displaying a sequence equal to that of selected fragments of the protease, but not belonging to any LES, as well as another peptide displaying a random sequence, were also used in the same way as peptide p-S 8 .
The sequences of these control peptides are QILIEICGHK and PLVTIKIGGQL corresponding to fragments 61-70 and 9-19, respectively, of the HIV-1-PR sequence, as well as the LSQETFDLWKLLPEN sequence, which is not related in any way to the protease. We will call these peptides K1, K2 and K3, respectively. To be noted that peptide K2 is rather hydrophobic and only > 70% purity could be achieved.
Each measure was performed recording the absorbance at 300 nm (4.13 eV) in a standard UV-vis spectrophotometer (Jasco V-560). The sample had a total volume of 70 µL in Spectrosil Far UV Quartz (170-2700 nm) cuvettes (3.3 mm optical path). The sample in the cuvette was exposed to a constant temperature (37 ± 0.05C) provided by continuous circulation of water from a waterbath to the cell holder via a circulation pump.
After proper thermal stabilization of the substrate dissolved in the buffer (pH 6), the absorbance at 300 nm was recorded. We performed 6 measures spanning a range of substrate concentrations from 50 µM to 250 µM. The reaction was initiated by adding 2.78 µg of enzyme and recording the asbsorbance decrease at 300 nm for 1200 sec. In all the reported measures the enzyme has thus a nominal concentration of 1.8 µM. Since, to our knowledge, no accurate measure has been published of the dimerization constant of HIV-1-PR at pH=6.0, it is difficult to estimate precisely the active site concentration in our assay. It should however be noted that the active site concentration only affects the estimation of k cat , and has no influence over the enzyme-inhibitor dissociation constants.
The assessment of the enzyme activity in presence of the inhibitor peptides followed a for the activity assays. The CD spectra were analyzed in terms of contribution of secondary structure elements [29] using the K2D method based on comparison with CD spectra of proteins and peptides with known secondary structure.
B. Results
In order to provide a quantitative measure of the enzymatic activity of HIV-1-PR and the inhibitory mechanism of the designed peptides, we have performed a Michaelis-Menten analysis of the data reported in Fig. 5(b) , measuring the initial reaction velocity v 0 at different substrate concentrations (cf. Fig. 5(a) ). We obtain an estimate of the dissociation constant K M for the uninhibited-enzyme/substrate complex (curve (2) of Fig. 5(b) ) of 670 ± 860 µM. The maximum velocity of the reaction v max results 0.40 ± 0.52 µM/s, corresponding to a catalitic rate k cat = 0.25 ± 0.28s −1 . Note that the order of magnitude of these results compares well with those reported for the same substrate in ref. [28] , that is K M = 280 ± 100µM and k cat = 7.3µM/s. The apparent dissociation constant K ′ M of the inhibited reaction is 332 ± 191µM, the maximum velocity being v max = 0.026 ± 0.011µM/s (cf. curve (1) of Fig. 5(b) ). The fact that the value v max changes in presence of the inhibitor while that of K ′ M remains within the experimental error of K M suggests that the inhibition is compatible with a non-competitive scenario [32] , in which the inhibitor can bind to the free enzyme with a dissociation constant K I or to the substrate-enzyme complex with a dissociation constant K ′ I not significantly different from K I . The results shown in Fig. 5(a) lead in fact to the values K I = 380 ± 810nM and K ′ I = 180 ± 234nM. The caveats and the physical meaning of the interpretation of Fig. 5(a) in terms of a classical mixed models will be examined in the next section.
We note that the large errors in the estimate of the kinetic parameters are due to the small number of points recorded. An alternative method to determine the value of these parameters involves the fitting of the data with the analytical solution of the MichaelisMenten kinetic [33] , solution which can be written in terms of the reduced concentation
Using a nonlinear fit to the data with the above expression one can obtain a more robust estimate of both K M and v max using the complete time-dependence of the concentration of free enzyme, expressed as a function of the measured absorbance as [S](t) = 1/[A(t) − A(∞)]/δǫ. In particular, using this method on curve (2) of Fig. 5(b) , we have been able to determine the kinetic values of the protease-substrate reaction obtaining K M = 656±320µM and k cat = 0.49 ± 0.08 s −1 . These values characterize more accurately the enzymatic process than the values obtained from the analysis reported in Fig. 5(a) .
We have repeated similar measures using this time the control peptides K1, K2 and K3
instead of peptide p-S 8 , and found no appreciable variation in the kinetic parameters with respect to the uninhibited case (cf. curve (3) and (4) The conformational properties of the inhibited protease have been investigated by means of UV circular dichroism experiments. The CD spectrum of the protease (cf. Fig. 6) under the same conditions used for the activity assay indicate a beta-sheet content of 79%, consistent with the beta character of the native conformation [17] . The CD spectrum of the solution of protease plus p-S 8 inhibitor, at the same concentrations and under the same conditions as those of the activity assay, shows a loss of beta-structure (to a beta-sheet content value of 45%), indicating that the protein is, to a large extent, in a non-folded conformation. These numbers compare well with those predicted by the model calculations (cf. caption to Fig. 4 ).
C. Discussion
The results described above show that the p-S 8 peptide inhibits the activity of the HIV-1-PR, interefering with the native character of its equilibrium state. Although a LineweaverBurk plot like that displayed in 5(a) is usually interpreted in terms of a non-competitive kind of inhibition, it can also describe the case of a irreversible binding of the inhibitor to the enzyme [32] . In fact, in a reaction of the kind (where I ≡p-S 8 )
where the rates k +I and k −I are much smaller than k +S and k −S , one can consider the This leads to a Michaelis-Menten equation identical to that associated with non-competitive inhibition, of the form
where we have set [34] , giving rise to a value of (k − I) −1 of the order of minutes.
V. CONCLUSIONS
The peptide p-S 8 (≡83N, 84I, 85I, 86G, 87R, 88N, 89L, 90L, 91T, 92Q, 93I) displaying a sequence identical to that of the S 8 LES of each of the two identical chains forming the HIV-1-PR homodimer is found to be a highly specific and likely quite efficient inhibitor (K I = 380 ± 810 nM) of the folding of the 99mers, and thus of the whole enzyme. A remarkable property of this inhibitor is that it is unlikely that it would allow for escape mutants. In fact, the only mutations which will prevent p-S 8 from acting are expected to involve protein denaturation.
Obvious disadvantages of the present design are the length and the peptidic character of the inhibitor, because it is not clear how to prevent the degradation by cellular enzymes.
Consequently, there are two clear tasks lying ahead. One, to investigate whether the shortening of p-S 8 , by leaving out some residues either at the beginning or at the end (or both), lead to peptides which still inhibit folding with similar specificity and effectiveness as p-S 8
does. The second is to develop molecules mimetic to p-S 8 or eventually to shorter peptides derived from p-S 8 .
We conclude by suggesting that the strategy employed to design p-S 8 , being universal, can be used to design inhibitors of the folding of other target proteins.
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